Contact us

Scaling human relevant brain organoids

Accelerating the development of life-changing therapies

Our solutions

Technology of minibrains

At BrainZell, we specialize in generating high-throughput brain organoids derived from induced pluripotent stem cells (iPSCs). Our innovative platform closely mimics human neural biology, utilizing an automated process with rigorous quality checks at every stage.

Learn more about our technology

Why BrainZell?

High throughput drug discovery platform

From neural activity testing and toxicity assessment to phenotypic assays, our technology empowers well-informed decisions on the efficacy and safety of compounds and biologics.

>10.000

Datapoints

Every week

Neural Activity & Potency

Assessing neural activity, viability and neuroinflammation.

Contact us

Early Neurological Risks

Identifying potential off-targets and side effects during target validation, lead optimization and preclinical research.

Contact us

Patient Relevance

Testing subgroup-related specifics with organoids from relevant donors. Simulating clinical trial-in-a-dish, including repeated exposures.

Contact us
Contact us

Pioneering the future
new CNS drug development

Human cortical models

Faithfully mimic the human brain

Mice are not humans, it's time to develop human brain medicines using human cell-based technologies and human relevant models.

Contact us to learn more

News

Discover our latest news and Scientific articles

Discover more articles
Published work about p53 in brain organoids.
Read article
Published work about 3D single-cell imaging in brain organoids
Read article
Published work about antiviral treatments of Zika virus tested in brain organoids.
Read article